Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Regulatory News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.025
Bid: 1.95
Ask: 2.10
Change: 0.00 (0.00%)
Spread: 0.15 (7.692%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.025
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

4 Aug 2021 16:41

RNS Number : 6116H
Shield Therapeutics PLC
04 August 2021
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMDZGGRKDMGMZM

Date   Source Headline
21st Feb 20247:00 amRNSUnaudited Full Year Trading Update
9th Jan 20247:00 amRNSAppointment of new Chief Financial Officer
7th Dec 20237:00 amRNSQ3 2023 U.S. Commercial Highlights
27th Nov 20235:24 pmRNSPDMR Transaction Notification
15th Nov 20237:30 amEQSHardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team
20th Oct 202311:45 amRNSAbstract to be presented at Healthcare Conference
12th Oct 20237:00 amRNSChief Financial Officer Transition
3rd Oct 20233:00 pmRNSResult of REX Retail Offer
3rd Oct 20237:00 amRNSBlock listing Interim Return
3rd Oct 20237:00 amRNSCompletion of SWK Financing
28th Sep 202312:50 pmRNSSuccessful completion of US$6.1m Equity Fundraise
28th Sep 20237:02 amRNSREX Retail Offer
28th Sep 20237:01 amRNS$20m secured debt facility &proposed equity raise
28th Sep 20237:00 amRNSInterim results update and business update
6th Sep 20237:00 amRNSNotice of Results and Change in reporting currency
25th Jul 20239:45 amEQSHardman & Co Research on Shield Therapeutics (STX): Accrufer Rx momentum gathering
24th Jul 20232:27 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSBusiness Update and U.S. Q2 2023 Highlights
28th Jun 20235:30 pmRNSResults of 2023 Annual General Meeting
16th Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
15th Jun 20234:35 pmRNSLapse of Offer
15th Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
15th Jun 20237:00 amRNSAcceptance Level Update
14th Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
14th Jun 20237:00 amRNSAcceptance Level Update
13th Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
13th Jun 20237:00 amRNSAcceptance Level Update
12th Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
12th Jun 20237:00 amRNSAcceptance Level Update
9th Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
9th Jun 20237:00 amRNSAcceptance Level Update
8th Jun 202312:31 pmRNSForm 8.3 - Shield Therapeutics PLC (amendment)
8th Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
8th Jun 20237:00 amRNSAcceptance Level Update
7th Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
6th Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
6th Jun 202310:10 amRNSGrant of share options to the CEO
5th Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
2nd Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
1st Jun 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
1st Jun 202311:00 amRNSHolding(s) in Company
1st Jun 202310:55 amRNSHolding(s) in Company
31st May 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
31st May 20237:00 amRNSTotal Voting Rights
30th May 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
26th May 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
25th May 20234:44 pmRNSPublication and posting of Offer Document
25th May 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
24th May 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc
23rd May 202312:00 pmRNSForm 8.5 (EPT/RI) - Shield Therapeutics Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.